Argos Therapeutics (FRA:77AA) Current Accrued Expense : €2.16 Mil (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Current Accrued Expense?

Argos Therapeutics's Current Accrued Expense for the quarter that ended in Sep. 2018 was €2.16 Mil.

Argos Therapeutics's quarterly Current Accrued Expense declined from Mar. 2018 (€2.36 Mil) to Jun. 2018 (€2.20 Mil) and declined from Jun. 2018 (€2.20 Mil) to Sep. 2018 (€2.16 Mil).

Argos Therapeutics's annual Current Accrued Expense increased from Dec. 2015 (€3.38 Mil) to Dec. 2016 (€9.46 Mil) but then declined from Dec. 2016 (€9.46 Mil) to Dec. 2017 (€1.07 Mil).

Argos Therapeutics Current Accrued Expense Historical Data

The historical data trend for Argos Therapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Current Accrued Expense Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Current Accrued Expense

Get a 7-Day Free Trial

1.32

1.14

3.38

9.46

1.07

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Current Accrued Expense	Get a 7-Day Free Trial															5.41	1.07	2.36	2.20	2.16

Argos Therapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Argos Therapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines